Pharma Deals Review, Vol 2008, No 94 (2008)

Font Size:  Small  Medium  Large

Galderma Acquires CollaGenex

Business Review Editor

Abstract


Galderma is to acquire CollaGenex Pharmaceuticals through a cash tender offer for all outstanding shares of CollaGenex’s common stock for approximately US$420 M at a price of US$16.60 per share.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.